| # | Drug | Count |
|---|---|---|
| 0 | FLUOXETINE | 13 |
| 1 | FLUOXETINE HYDROCHLORIDE | 13 |
| 2 | RISPERIDONE | 11 |
| 3 | DIAZEPAM | 10 |
| 4 | DIAZEPAM ORAL | 10 |
| 5 | DIAZEPAM ORAL SOLUTION (CONCENTRATE) | 10 |
| 6 | LORAZEPAM | 10 |
| 7 | METHYLPHENIDATE HYDROCHLORIDE | 10 |
| 8 | QUETIAPINE | 10 |
| 9 | SERTRALINE | 10 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DACTINOMYCIN | 6 | 0.0027 |
| 1 | NITISINONE | 1 | 0.0010 |
| 2 | RUFINAMIDE | 2 | 0.0008 |
| 3 | GUANFACINE | 6 | 0.0007 |
| 4 | ETHOSUXIMIDE | 1 | 0.0004 |
| 5 | LISDEXAMFETAMINE DIMESYLATE CAPSULES | 2 | 0.0004 |
| 6 | FAMCICLOVIR | 1 | 0.0004 |
| 7 | ICATIBANT ACETATE | 2 | 0.0003 |
| 8 | GAUNFACINE | 1 | 0.0003 |
| 9 | PERAMPANEL | 2 | 0.0003 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 18 |
| 1 | Benzodiazepine [EPC] | 11 |
| 2 | Central Nervous System Stimulant [EPC] | 8 |
| 3 | Alkylating Drug [EPC] | 7 |
| 4 | Actinomycin [EPC] | 6 |
| 5 | Anti-epileptic Agent [EPC] | 5 |
| 6 | Central alpha-2 Adrenergic Agonist [EPC] | 5 |
| 7 | Integrin Receptor Antagonist [EPC] | 4 |
| 8 | Platinum-based Drug [EPC] | 4 |
| 9 | Interferon beta [EPC] | 3 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 6 | 0.0027 |
| 1 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 3 | 0.0024 |
| 2 | 4-Hydroxyphenyl-Pyruvate Dioxygenase Inhibitor [EPC] | 1 | 0.0012 |
| 3 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 2 | 0.0003 |
| 4 | Central alpha-2 Adrenergic Agonist [EPC] | 5 | 0.0001 |
| 5 | Central Nervous System Stimulant [EPC] | 8 | 0.0001 |
| 6 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 7 | Integrin Receptor Antagonist [EPC] | 4 | 0.0000 |
| 8 | Hemoglobin S Polymerization Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Atypical Antipsychotic [EPC] | 18 | 0.0000 |